Loading stock dataβ¦
$2.45-0.10 (-3.87%)
SS Innovations International, Inc., together with its subsidiaries, operates as a commercial-stage surgical robotics company in India, Philippines, Indonesia, South America, Iraq, Cyprus, Oman, United Arab Emirates (UAE), Nepal, and internationally.
SS Innovations International, Inc. in the Healthcare sector is trading at $2.45 with a market capitalization of $655M. Wall Street consensus targets $7.00 (1 analysts), implying a +185.6% move over the next 12 months. The stock is currently near its 52-week low of $2.43, remaining 39.8% below its 200-day moving average. On fundamentals, Piotroski 5/9 shows mixed financial quality, Altman Z in the safe zone. Risk note: RSI 22 is oversold, raising the odds of a near-term bounce; MACD remains below its signal line. The Whystock Score of 90/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $13.94Mβ | $11.10Mβ | $14.53Mβ | $12.83Mβ | $10.00M |
| Gross Profit | $7.10Mβ | $5.33Mβ | $6.38Mβ | $6.16Mβ | $5.92M |
| Operating Income | -$2.27Mβ | -$3.64Mβ | -$734,997β | -$1.84Mβ | $97,014 |
| Net Income | -$2.66Mβ | -$3.58Mβ | -$2.47Mβ | -$3.72Mβ | -$256,691 |
SS Innovations International, Inc., together with its subsidiaries, operates as a commercial-stage surgical robotics company in India, Philippines, Indonesia, South America, Iraq, Cyprus, Oman, United Arab Emirates (UAE), Nepal, and internationally. ...